NCT00455455

Brief Summary

The primary objective of this study is to compare subjective symptoms and ocular health in a group of individuals who are currently wearing soft contact lenses on a daily wear basis, after a short period of no lens wear and during the time course when using differing care regimens.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Mar 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2007

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

March 23, 2007

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 3, 2007

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

July 12, 2010

Completed
Last Updated

July 12, 2010

Status Verified

June 1, 2010

Enrollment Period

1.8 years

First QC Date

March 23, 2007

Results QC Date

January 5, 2010

Last Update Submit

June 9, 2010

Conditions

Outcome Measures

Primary Outcomes (4)

  • Corneal Sensitivity

    The detection threshold, the lowest level at which a stimulus to the cornea in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.

    baseline

  • Corneal Sensitivity

    The detection threshold, the lowest level at which a stimulus to the cornea in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.

    day 7

  • Conjunctival Sensitivity

    The detection threshold, the lowest level at which a stimulus to the conjunctiva in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.

    baseline

  • Conjunctival Sensitivity

    The detection threshold, the lowest level at which a stimulus to the conjunctiva in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.

    day 7

Secondary Outcomes (2)

  • Corneal Staining Grade

    baseline

  • Corneal Staining Grade

    day 7

Study Arms (2)

Optifree RepleniSH Multipurpose Disinfecting Solution

ACTIVE COMPARATOR
Drug: Optifree RepleniSH Multipurpose Disinfecting Solution

ReNu Multiplus Multipurpose Solution

ACTIVE COMPARATOR
Drug: ReNu Multiplus Multipurpose Solution

Interventions

lens care system

Also known as: lens care system
Optifree RepleniSH Multipurpose Disinfecting Solution

lens care system

Also known as: lens care system
ReNu Multiplus Multipurpose Solution

Eligibility Criteria

Age17 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • An eligible participant is one who:
  • Is between 17-45 years old and has full legal capacity to volunteer.
  • Has read and signed an information consent letter, after having the opportunity to ask questions and receive acceptable answers.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Does not experience any dryness related symptoms during lens wear (i.e. at least 12 hours of comfortable wearing time)
  • Is correctable to a visual acuity of 6/7.5 (20/25) or better (each eye) with their habitual vision correction.
  • Has normal binocular vision (no strabismus, no amblyopia).
  • Has clear corneas and no active ocular disease.
  • Has had an ocular examination in the last two years. Has a distance contact lens prescription between +0.50D to +6.00 DS and -0.50D and -12.00 DS.
  • Has astigmatism less than or equal to -1.00DC.
  • Agrees to wear the study lenses on a daily wear basis.
  • Has a pair of glasses with updated prescription and agrees to wear them during the period no lens wear (7-10 days) as required by the study.

You may not qualify if:

  • A person is ineligible if he/she:
  • Has undergone corneal refractive surgery.
  • Is aphakic.
  • Has any active ocular disease.
  • Has any systemic disease affecting ocular health.
  • Is using any systemic or topical medications that may affect ocular health.
  • Has a known sensitivity to the diagnostic pharmaceuticals to be used in the study.
  • Is pregnant or lactating.
  • Is participating in any other clinical or research study.
  • Has a known clinically significant sensitivity to the contact lens care solutions used in the study.
  • Has ocular or systemic allergies that could adversely affect contact lens wear.
  • Currently wears lenses on a continuous or extended wear basis.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (dry eyes) that would affect the wearing of contact lenses.
  • Has pinguecula/pterygium that, in the investigator's judgment, makes contact lens wear inadvisable.
  • Is a rigid lens wearer.
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Contact Lens Research, School of Optometry

Waterloo, Ontario, N2L 3G1, Canada

Location

Related Publications (1)

  • Situ P, Simpson TL, Jones LW, Fonn D. Effects of silicone hydrogel contact lens wear on ocular surface sensitivity to tactile, pneumatic mechanical, and chemical stimulation. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6111-7. doi: 10.1167/iovs.09-4807. Epub 2010 Jun 30.

MeSH Terms

Conditions

MyopiaHyperopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Limitations and Caveats

Sample size completed as anticipated.

Results Point of Contact

Title
Dr Craig A Woods
Organization
CCLR

Study Officials

  • Desmond Fonn, M.Optom

    University of Waterloo

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 23, 2007

First Posted

April 3, 2007

Study Start

March 1, 2007

Primary Completion

December 1, 2008

Study Completion

December 1, 2008

Last Updated

July 12, 2010

Results First Posted

July 12, 2010

Record last verified: 2010-06

Locations